The Scientist

» epigenetics, evolution and disease/medicine

Most Recent

image: Contributors

Contributors

By Catherine Offord and Jef Akst | September 1, 2017

Meet some of the people featured in the September 2017 issue of The Scientist.

0 Comments

image: Discovery of the Malaria Parasite, 1880

Discovery of the Malaria Parasite, 1880

By Shawna Williams | September 1, 2017

Most didn’t believe French doctor Charles Louis Alphonse Laveran when he said he’d spotted the causative agent of the disease—and that it was an animal.

0 Comments

image: Far-Out Science

Far-Out Science

By Mary Beth Aberlin | September 1, 2017

How psychedelic drugs and infectious microbes alter brain function

0 Comments

image: Decoding the Tripping Brain

Decoding the Tripping Brain

By Diana Kwon | September 1, 2017

Scientists are beginning to unravel the mechanisms behind the therapeutic effects of psychedelic drugs.

2 Comments

image: Infographic: The Brain on Psychedelics

Infographic: The Brain on Psychedelics

By Diana Kwon | September 1, 2017

Understanding how hallucinogenic drugs affect different neural networks could shed light on their therapeutic potential.

0 Comments

image: Infographic: The Various Forms of Methylated DNA

Infographic: The Various Forms of Methylated DNA

By Skirmantas Kriaucionis | September 1, 2017

To expand the basic nucleotide alphabet, many species modify their DNA with epigenetic marks.

0 Comments

The new technique helped pig tibias heal in just eight weeks.

0 Comments

image: The Role of DNA Base Modifications

The Role of DNA Base Modifications

By Skirmantas Kriaucionis | September 1, 2017

Researchers are just beginning to scratch the surface of how several newly recognized epigenetic changes function in the genome.

3 Comments

image: Smoking on a Chip

Smoking on a Chip

By The Scientist Staff | September 1, 2017

A new device from the Wyss Institute at Harvard University simulates the effects of cigarette smoke on human lungs.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By Jef Akst | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

Popular Now

  1. Stem Cell Vaccine Protects Mice From Cancer
  2. Love in the Scientific Literature
    News Analysis Love in the Scientific Literature

    There are countless ways for scientists to say, “I love you.” Naming a slime-mold beetle after your wife (and another after your ex-wife) is, apparently, one of them.  

  3. DNA Robots Target Cancer
    Daily News DNA Robots Target Cancer

    Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.

  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS